Energy balance in congenital generalized lipodystrophy type I

Metabolism: Clinical and Experimental

Volumn 57, Issue 8, 2008, Pages 1155-1161

  Taleban, Sasha ^a,b   Carew, Heather T ^b,c   Dichek, Helén L ^d   Deeb, Samir S ^d   Hollenback, David ^c   Weigle, David S ^b   Cummings, David E ^b   Brunzell, John D ^b  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Cell Therapeutics   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; ACYLTRANSFERASE; ADIPONECTIN; AGPAT2 ENZYME; GHRELIN; LEPTIN;

ADULT; ARTICLE; CASE REPORT; CONGENITAL GENERALIZED LIPODYSTROPHY TYPE 1; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; ENZYME ACTIVITY; FEMALE; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; LIPODYSTROPHY; MALE; METABOLIC RATE; PRIORITY JOURNAL;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ADIPONECTIN; ADULT; BASAL METABOLISM; DNA; ENERGY METABOLISM; FEMALE; GENOTYPE; GHRELIN; HUMANS; LEPTIN; LINEAR MODELS; LIPODYSTROPHY, CONGENITAL GENERALIZED; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 47149106476     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.04.008     Document Type: Article

References (38)

1. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab 14 (1954) 193-204
2. Brunzell J.D., Shankle S.W., and Bethune J.E. Congenital generalized lipodystrophy accompanied by cystic angiomatosis. Ann Int Med 69 (1968) 501-516
3. Garg A., Wilson R., Barnes R., Arioglu E., Zaidi Z., Gurakan F., et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab 84 (1999) 3390-3394
4. Agarwal A.K., Arioglu E., de Almeida S., Akkoc N., Taylor S.I., Bowcock A.M., et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31 (2002) 21-23
5. Haque W., Garg A., and Agarwal A.K. Enzymatic activity of naturally occurring 1-acyglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy. Biochem Biophys Res Commun 327 (2005) 446-453
6. Seip M. Lipodystrophy and gigantism with associated endocrine manifestations: a new diencephalic syndrome?. Acta Paediatr 48 (1959) 555-574
7. Magre J., Delepine M., Khallouf E., Gedde-Dahl Jr. T., Van Maldergem L., Sobel E., et al., BSCL Working Group. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28 (2001) 365-370
8. Windpassinger C., Auer-Grumbach M., Irobi J., Patel H., Petek E., Horl G., et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silber syndrome. Nat Genet 36 (2004) 271-276
9. Seip M., and Trygstad O. Generalized lipodystrophy. Acta Paediatr Suppl 413 (1996) 2-28
10. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 (1997) 903-908
11. Simha V., and Garg A. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes. J Clin Endocrinol Metab 88 (2003) 5433-5437
12. Agarwal A.K., Simha V., Oral E.A., Moran S.A., Gorden P., O'Rahilly S., et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 88 (2003) 4840-4847
13. Petersen K.F., Oral E.A., Dufour S., Befroy D., Ariyan C., Yu C., et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109 (2002) 1345-1350
14. Reitman M.L., Arioglu E., Gavrilova O., and Taylor S.I. Lipoatrophy revisited. Trends Endocrinol Metab 11 (2000) 410-416
15. Agarwal A.K., and Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med 57 (2006) 297-311
16. Javor E.D., Cochran E.K., Musso C., Young J.R., DePaoli A.M., and Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54 (2005) 1994-2002
17. Haque W.A., Shimomura I., Matsuzawa Y., and Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87 (2002) 2395-2398
18. Weigle D.S., Sande K.J., Per-Henrik I., Monsen E.R., and Brunzell J.D. Weight loss leads to a marked decrease in nonresting energy expenditure in ambulatory human subjects. Metabolism 37 (1988) 930-936
19. Hideshima T., Chauhan D., Hayashi T., Podar K., Akiyama M., Mitsiades C., et al. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma. Cancer Res 63 (2003) 8428-8436
20. Hansen N.J., Lohman T.G., Going S.B., Hall M.C., Pamenter R.W., Bare L.A., et al. Prediction of body composition in premenopausal females from dual-energy x-ray absorptiometry. J Appl Physiol 75 (1993) 1637-1641
21. Withers R.T., Smith D.A., Chatterton B.E., Schultz C.G., and Gaffney R.D. A comparison of four methods of estimating the body composition of male endurance athletes. Eur J Clin Nutr 46 (1992) 773-784
22. Grande F., and Keys A. Body weight, body composition, and calorie status. In: Goodhart R., and Shils M. (Eds). Modern nutrition in health and disease (1980), Lea and Febiger, Philadelphia 3-34
23. Ravussin E., Lillioja S., and Anderson T.E. Determinations of 24-hour energy expenditure in man: methods and results using a respiratory chamber. J Clin Invest 78 (1986) 1568-1578
24. Mifflin M.D., St Jeor S.T., Scott B.J., Daugherty S.A., and Koh Y.O. A new predictive equation for resting energy expenditure in healthy adults. Am J Clin Nutr 51 (1990) 241-247
25. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
26. Carew H.T., Taleban S., Dichek H.L., Bonham L., Hollenback D., and Brunzell J.D. Low levels of LPAAT beta activity in congenital generalized lipodystrophy. J Invest Med 53 (2005) S157
27. Taleban S., and Brunzell J.D. Energy balance in congenital generalized lipodystrophy type I. J Invest Med 52 (2004) S153
28. Schwartz R., Schafer I.A., and Renold A.E. Generalized lipoatrophy, hepatic cirrhosis, disturbed carbohydrate metabolism and accelerated growth (lipoatrophic diabetes). Am J Med 28 (1960) 973-985
29. Savage D.B., Murgatroyd P.R., Chatterjee K.V., and O'Rahilly S. Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy. J Clin Endocrinol Metab 90 (2005) 1446-1452
30. Oral E.A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 346 (2002) 570-578
31. Klein S., Jahoor F., Wolfe R.R., and Stuart C.A. Generalized lipodystrophy: in vivo evidence for hypermetabolism and insulin-resistant lipid, glucose, and amino acid kinetics. Metabolism 41 (1992) 893-896
32. Bhayana S., Siu V.M., Joubert G.I., Clarson C.L., Cao H., and Hegele R.A. Cardiomyopathy in congenital complete lipodystrophy. Clin Genet 61 (2002) 283-287
33. Van Maldergem L., Magre J., Khallouf T.E., Gedde-Dahl T., Delepine M., Trygstad O., et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet 39 (2002) 722-733
34. Campfield L.A., Smith F.J., Guisez Y., Devos R., and Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 475-476
35. D'Andrea F., Grella R., Rizzo M.R., Grella E., Grella R., Nicoletti G., et al. Changing the metabolic profile by large-volume liposuction: a clinical study conducted with 123 obese women. Aesthetic Plast Surg 29 (2005) 472-481
36. Talisman R., Belinson N., Modan-Moses D., Canti H., Orenstein A., Barzilai Z., et al. The effect of reduction of the peripheral fat content by liposuction-assisted lipectomy (SAL) on serum leptin levels in postoperative period: a prospective study. Aesthetic Plast Surg 25 (2001) 262-265
37. Elif O.A., Ruiz E., Andewelt A., Sebring N., Wagner A.J., DePaoli A.M., et al. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab 87 (2002) 3110-3117
38. Cummings D.E., Foster-Schubert K.E., and Overduin J. Ghrelin and energy balance: focus on current controversies. Curr Drug Target 6 (2005) 153-169